You are here :
Home
Healthcare Market Research Reports
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
European Brachytherapy The European Brachytherapy Market was pegged at $50 million in 2013 and expected to be $54 million by 2018. The report “European Brachytherapy Market forecast, 2010-2018 “analyzes the market of devices by segments such as High Dose Rate Brachytherapy, Pulsed Dose Rate Brachytherapy, and Permanent Seed Brachytherapy. The main companies operating in European Brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden). |
Upcoming |
|
|
Asia-Pacific Brachytherapy The Asia-Pacific Radiation Ablation Market was pegged at $32 million in 2013 and expected to be $38 million by 2018. Brachytherapy involves the implantation of radioactivity within the body to ablate or kill cancer or tumour cells within or in close proximity to the target area in the body. The main companies operating in Asia-Pacific brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden). |
Upcoming |
|
|
Americas Brachytherapy The American Brachytherapy Market was pegged at $129 million in 2013 and expected to be $146 million by 2018. Brachytherapy involves the implantation of radioactivity within the body to ablate or kill cancer or tumour cells within or in close proximity to the target area in the body. The main companies operating in Brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden). |
Upcoming |
|
|
European Pre-clinical Imaging Devices Market The European Pre-Clinical Imaging Devices Market, mainly driven by aging population, technological advancements, low cost of the treatment, and increasing prevalence to various diseases such as cancer and heart related disorders. The report “European Pre-Clinical Imaging Devices Market forecast, 2008-2018 “analyzes the market of devices majorly on the basis of technologies. Geographically, the European Pre-Clinical Imaging Devices Market is mainly segmented into U.K., Germany, France, Italy, Spain, and Rest of Europe. The report European Pre-Clinical Imaging Devices Market also provides an extensive competitive landscaping of companies operating in this market. |
Upcoming |
|
|
European Proton Radiotherapy Systems Market The European Proton Radiotherapy Systems Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $82.1 million in 2013 and expected to be $95.0 million by 2018, growing at a CAGR of 3.0%. The Proton Radiotherapy Systems Market analyzes the market of devices by 2 segments such as Cyclotron for proton therapy, and Synchrotron for proton therapy. The prominent players in the Radiotherapy Devices Market globally areVarian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc, Mevion Medical Systems, Inc. |
Upcoming |
|
|
North American Pre-clinical Imaging Devices Market The North American Pre-Clinical Imaging Devices Market, mainly driven by aging population, technological advancements, low cost of the treatment, and increasing prevalence to various diseases such as cancer and heart related disorders. The report “North American Pre-Clinical Imaging Devices Market forecast, 2008-2018 “analyzes the market of devices majorly on the basis of technologies. Geographically, the market is mainly segmented into U.S., Canada, and Mexico. The report North American Pre-Clinical Imaging Devices Market also provides an extensive competitive landscaping of companies operating in this market. |
Upcoming |
|
|
European Non-Knowledge based Clinical decision support systems (CDSS) The European non-knowledge based clinical decision support systems (CDSS) market was estimated at $3 million in 2012, and is expected to reach $3.4 million by 2018, at a CAGR of 2.2%.The non-knowledge based CDSS market can be segmented by geography, application, technology, product, and end-user. Deep dive analysis of key market players are also considered in this report. |
Upcoming |
|
|
Asian Non-Knowledge based Clinical decision support systems (CDSS) The Asian non-knowledge based CDSS market was valued at $3 million in 2012, and is projected to reach $3.4 million by 2018, at a CAGR of 2.4%.The non-knowledge based CDSS market is segmented by geography, application, technology, product, and end-user. Deep dive analysis of key market players have also been considered in this report. |
Upcoming |
|
|
Asian Proton Radiotherapy Systems Market The Asian Proton Radiotherapy Systems Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $32.7 million in 2013 and expected to be $46.6 million by 2018, growing at a CAGR of 7.4%. The Proton Radiotherapy Systems Market analyzes the market of devices by 2 segments such as Cyclotron for proton therapy, and Synchrotron for proton therapy. The prominent players in the Radiotherapy Devices Market globally areVarian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc, Mevion Medical Systems, Inc. |
Upcoming |
|
|
North American Polysomnography (PSG) Device The North American Polysomnography (PSG) Devices market has gained tremendous importance owing to the large patient pool for Obstructive Sleep Apnea (OSA). The market is clinched at $1.3 billion in 2013 and is expected to reach a value of $2.5 billion in 2018, with a CAGR of 14.7% from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report. |
Upcoming |
|
|
North American E-Prescribing (e-Rx) The North American E-Prescribing (e-Rx), mainly driven by growing popularity of e-priscripttion, was pegged at $84.43 million in 2013 and expected to be $328.14 million by 2018, growing at a CAGR of 31.2% from 2013 to 2018. E-Prescribing (e-Rx) systems market segmentation by products (Stand-alone and integrated), deployment modes( Licensed(On-premise, Web-hosted, Cloud hosted), usage mode(PC-based and Hand Held), components( Hardware, Software and Services), end users ( Hospitals and Office based physicians) , and geography. The major companies operating in E-Prescribing (e-Rx), market and extensively covered in the report are Cerner Corporation (U.S.), Allscripts (U.S), Quality Systems Inc. (U.S.), Emdeon (U.S.), and Athenahealth (U.S.), eclinical Works(U.S.), Practice Fusion (U.S.) |
Upcoming |
|
|
European BioProduction Market The European BioProduction Market, mainly driven by increasing in-vitro research activities, increasing demand for vaccines and cellular medicine. The report “European BioProduction Market forecast, 2008-2018 “analyzes the market by 5 main segments such as tissue engineering, cell culture, protein engineering, biomaterials, and micro-reactor. Geographically, the European BioProduction Market is mainly segmented into U.K., Germany, France, Italy, Spain, and Rest of Europe. The report European BioProduction Market also provides an extensive competitive landscaping of companies operating in this market. |
Upcoming |
|
|
European E-Prescribing (e-Rx) The European E-Prescribing (e-Rx), mainly driven by growing popularity of e-priscripttion, was pegged at $163.62 million in 2013 and expected to be $468.0 million by 2018, growing at a CAGR of 23.4% from 2013 to 2018. E-Prescribing (e-Rx) systems market segmentation segmentation by products (Stand-alone and integrated), deployment modes( Licensed(On-premise, Web-hosted, Cloud hosted), usage mode(PC-based and Hand Held), components( Hardware, Software and Services), end users ( Hospitals and Office based physicians) , and geography. The major companies operating in E-Prescribing (e-Rx), market and extensively covered in the report are Cerner Corporation (U.S.), Allscripts (U.S), Quality Systems Inc. (U.S.), Emdeon (U.S.), and Athenahealth (U.S.), eclinical Works(U.S.), Practice Fusion (U.S.) |
Upcoming |
|
|
Asian E-Prescribing (e-Rx) The Asian E-Prescribing (e-Rx), mainly driven by growing popularity of e-priscripttion, was pegged at $71.49 million in 2013 and expected to be $232.22 million by 2018, growing at a CAGR of 26% from 2013 to 2018. E-Prescribing (e-Rx) systems market segmentation by products (Stand-alone and integrated), deployment modes( Licensed(On-premise, Web-hosted, Cloud hosted), usage mode(PC-based and Hand Held), components( Hardware, Software and Services), end users ( Hospitals and Office based physicians) , and geography. The major companies operating in E-Prescribing (e-Rx), market and extensively covered in the report are Cerner Corporation (U.S.), Allscripts (U.S), Quality Systems Inc. (U.S.), Emdeon (U.S.), and Athenahealth (U.S.), eclinical Works(U.S.), Practice Fusion (U.S.) |
Upcoming |
|
|
European Polysomnography (PSG) Device The European Polysomnography (PSG) Devices market has gained tremendous importance owing to the large patient pool for Obstructive Sleep Apnea (OSA). The market is clinched at $526.2 million in 2013 and is expected to reach a value of $1.0 billion in 2018, with a CAGR of 14.2% from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report. |
Upcoming |
|
|
Asian Polysomnography (PSG) Device The Asian Polysomnography (PSG) Devices market has gained tremendous importance owing to the large patient pool for Obstructive Sleep Apnea (OSA). The market is clinched at $292.7 million in 2013 and is expected to reach a value of $611.3 million in 2018, with a CAGR of 15.9% from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report. |
Upcoming |
|
|
North American Ophthalmology Diagnostic and Monitoring Devices The North American market for ophthalmology diagnostic and monitoring devices was valued at $675.7 million in 2013 expected to be growing at a CAGR of 4.4% from 2013 to 2018. ophthalmology diagnostic and monitoring devices can be segmented by Geographies, Products, Endusers, Companies and MacroIndicators. Deep dive analysis of the top players of this market have been considered in this report. |
Upcoming |
|
|
European Ophthalmology Diagnostic and Monitoring Devices Europe has been considered as the second largest market in ophthalmology surgery devices, with 25.41% of the market share, which is expected to grow at a CAGR of 3.69% from 2012 to 2018. The European ophthalmology surgery devices report offers a comprehensive analysis of the key market drivers, restraints, and upcoming opportunities. It also focuses on the current market trends and provides key market profiles of companies that thrive in this market. |
Upcoming |
|
|
Europe Hematology Europe holds second largest market position after North America. Germany commanded the largest share 20% of the Europe hematology market at an estimated $272.8 million in 2013 and is expected to reach $349.7 million by 2018, at a CAGR of 5.4% from 2013 to 2018. The report “European Hematology Market forecast for 2018 “analyzes the market by 2 segments such as hematology reagents and hematology instruments. |
Upcoming |
|
|
North American Positive Airway Pressure (PAP) The North American Polysomnography (PSG) Devices market has gained tremendous importance owing to the large patient pool for Obstructive Sleep Apnea (OSA) as it forms the first line of treatment used for Sleep Apnea. The market is clinched at $2.7 billion in 2013 and is expected to reach a value of $6.0 billion in 2018, with a CAGR of 17.23 from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report. |
Upcoming |
Healthcare
